A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
← catalyst calendarNCT05767047 · readout in 3,498 d
Sponsored by Amgen (industry) · AMGN — their whole pipeline →.
Phase
Phase 3
Status
Recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
48estimated
Sites
7
Countries
Greece, Israel, Spain +1
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-03-23 | actual | When the study began enrolling |
| Primary completion | 2036-03-17 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2036-03-17 | estimated | The whole study's end, after follow-up |
| First posted | 2023-03-14 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-12-01 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Behçet's Disease
- Juvenile Psoriatic Arthritis
Intervention
- Drug: Apremilast — also filed as AMG 407, Otezla, CC-10004
Primary outcomes
what the primary-completion date above is the date OFNumber of Participants with Adverse Events
measured Up to approximately 4 years
Columbia-Suicide Severity rating Scale (C-SSRS)
measured Up to approximately 4 years
Tanner Staging
measured Up to approximately 4 years
Change from Baseline in Body Weight
measured Up to approximately 4 years
Change from Baseline in Height
measured Up to approximately 4 years
Change from Baseline in Body Mass Index (BMI)
measured Up to approximately 4 years
Number of Participants with Clinically Significant Changes in Vital Signs
measured Up to approximately 4 years
Number of Participants with Clinically Significant Changes in Laboratory Parameters
measured Up to approximately 4 years
Permalink · AMGN's whole pipeline · Catalyst calendar · Every registered study · What changed